Saphris OK'd for schizophrenia

Friday, August 14, 2009 - 11:21 in Health & Medicine

WASHINGTON, Aug. 14 (UPI) -- Schering-Plough Corp.'s asenapine has been cleared for sale as a treatment for schizophrenia and bipolar disorder in adults, U.S. authorities said.

Read the whole article on UPI

More from UPI

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net